AR012989A1 - Novedosos inhibidores de sulfonamida de la farnesil-protein trasnferasa. - Google Patents
Novedosos inhibidores de sulfonamida de la farnesil-protein trasnferasa.Info
- Publication number
- AR012989A1 AR012989A1 ARP980102859A ARP980102859A AR012989A1 AR 012989 A1 AR012989 A1 AR 012989A1 AR P980102859 A ARP980102859 A AR P980102859A AR P980102859 A ARP980102859 A AR P980102859A AR 012989 A1 AR012989 A1 AR 012989A1
- Authority
- AR
- Argentina
- Prior art keywords
- novel sulfonamide
- farnesil
- protein transferase
- sulfonamide inhibitors
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87705097A | 1997-06-17 | 1997-06-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR012989A1 true AR012989A1 (es) | 2000-11-22 |
Family
ID=25369146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980102859A AR012989A1 (es) | 1997-06-17 | 1998-06-16 | Novedosos inhibidores de sulfonamida de la farnesil-protein trasnferasa. |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0989980A1 (ja) |
JP (1) | JP2002507192A (ja) |
KR (1) | KR20010013826A (ja) |
CN (1) | CN1267290A (ja) |
AR (1) | AR012989A1 (ja) |
AU (1) | AU8253698A (ja) |
CA (1) | CA2293358C (ja) |
CO (1) | CO4940475A1 (ja) |
HU (1) | HUP0004627A2 (ja) |
IL (1) | IL133393A0 (ja) |
NZ (1) | NZ501619A (ja) |
PE (1) | PE86199A1 (ja) |
WO (1) | WO1998057949A1 (ja) |
ZA (1) | ZA985218B (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6689789B2 (en) | 1997-06-17 | 2004-02-10 | Schering Corporation | Compounds useful for inhibition of farnesyl protein transferase |
US7517884B2 (en) | 1998-03-30 | 2009-04-14 | Kalypsys Inc. | Sulfonyl-substituted bicyclic compounds as modulators of PPAR |
US7342016B2 (en) | 2000-08-30 | 2008-03-11 | Schering Corporation | Farnesyl protein transferase inhibitors as antitumor agents |
JP2004514717A (ja) * | 2000-11-29 | 2004-05-20 | シェーリング コーポレイション | 新規ファルネシルプロテイントランスフェラーゼインヒビター |
BRPI0516435B1 (pt) | 2004-10-29 | 2021-09-21 | Kalypsys , Inc | Composto, e composição farmacêutica |
EP1940815B1 (en) | 2005-10-25 | 2018-08-15 | Kalypsys, Inc. | Salts of modulators of ppar and methods of treating metabolic disorders |
WO2008091863A1 (en) | 2007-01-23 | 2008-07-31 | Kalypsys, Inc. | Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis |
MX2015010407A (es) * | 2013-02-19 | 2015-10-26 | Icahn School Med Mount Sinai | Heterociclos triciclicos como agentes anticancer. |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA947969B (en) * | 1993-10-15 | 1996-07-12 | Schering Corp | Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
IL117798A (en) * | 1995-04-07 | 2001-11-25 | Schering Plough Corp | Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them |
IL117797A0 (en) * | 1995-04-07 | 1996-08-04 | Pharmacopeia Inc | Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
-
1998
- 1998-06-15 JP JP54752198A patent/JP2002507192A/ja active Pending
- 1998-06-15 ZA ZA985218A patent/ZA985218B/xx unknown
- 1998-06-15 EP EP98932718A patent/EP0989980A1/en not_active Withdrawn
- 1998-06-15 CA CA002293358A patent/CA2293358C/en not_active Expired - Fee Related
- 1998-06-15 WO PCT/US1998/011508 patent/WO1998057949A1/en not_active Application Discontinuation
- 1998-06-15 KR KR1019997011846A patent/KR20010013826A/ko not_active Application Discontinuation
- 1998-06-15 CN CN98808186A patent/CN1267290A/zh active Pending
- 1998-06-15 PE PE1998000508A patent/PE86199A1/es not_active Application Discontinuation
- 1998-06-15 HU HU0004627A patent/HUP0004627A2/hu unknown
- 1998-06-15 NZ NZ501619A patent/NZ501619A/en unknown
- 1998-06-15 AU AU82536/98A patent/AU8253698A/en not_active Abandoned
- 1998-06-15 IL IL13339398A patent/IL133393A0/xx unknown
- 1998-06-16 CO CO98034142A patent/CO4940475A1/es unknown
- 1998-06-16 AR ARP980102859A patent/AR012989A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
NZ501619A (en) | 2002-02-01 |
PE86199A1 (es) | 1999-09-24 |
ZA985218B (en) | 1998-12-15 |
WO1998057949A1 (en) | 1998-12-23 |
IL133393A0 (en) | 2001-04-30 |
CN1267290A (zh) | 2000-09-20 |
AU8253698A (en) | 1999-01-04 |
CA2293358A1 (en) | 1998-12-23 |
CO4940475A1 (es) | 2000-07-24 |
EP0989980A1 (en) | 2000-04-05 |
CA2293358C (en) | 2008-08-05 |
HUP0004627A2 (hu) | 2001-10-28 |
KR20010013826A (ko) | 2001-02-26 |
JP2002507192A (ja) | 2002-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9713465A (pt) | Inibidores metalotprotease de amina cìclica sibstituìda | |
ES2161291T3 (es) | N-(indol-2-carbonil)amidas y derivados como inhibidores de la glucogeno fosforilasa. | |
AR003938A1 (es) | Compuestos triciclicos de urea utiles para la inhibicion de la funcion de la proteina g y para tratamiento de enfermedades proteoliticas, composicionfarmaceutica, y el uso de los mismos para la preparacion de medicamentos. | |
MX9206008A (es) | Inhibidores de enzima proteolitica, derivados de sacarina 2-substituida. | |
TR199800825T2 (xx) | Farnesil protein transferini inhibe eden (imidazol-5-il) metil-2-kinolinon t�revleri. | |
BR9814340A (pt) | Derivados de indol como inibidores de fator xa | |
DE69432035D1 (de) | Saccharinderivate als proteolytische Enzyminhibitoren | |
BR9809342A (pt) | Composto, composição farmacêutica, e, uso do composto | |
BR9811099A (pt) | Inibidores de urocinase | |
Fenton et al. | Biogenesis of the mitochondrial enzyme methylmalonyl-CoA mutase. Synthesis and processing of a precursor in a cell-free system and in cultured cells. | |
BR9713178A (pt) | Inbidores espirocìclicos da metaloprotease. | |
Malemud et al. | Identification of neutral proteases in human neutrophil granules that degrade articular cartilage proteoglycan | |
AR012989A1 (es) | Novedosos inhibidores de sulfonamida de la farnesil-protein trasnferasa. | |
Hope et al. | Secretory phospholipase A 2 inhibitors and calmodulin antagonists as inhibitors of cytosolic phospholipase A 2 | |
EA200000240A1 (ru) | Соединения, препятствующие эффекту раннего превращения лекарственных средств | |
CA2266759A1 (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase | |
EA199800544A1 (ru) | Тиольные производные, обладающие ингибирующей активностью в отношении металлопептидаз | |
AR009809A1 (es) | Derivados de 10,13,15-trioxatriciclo[9.2.1(9.6)]-pentadecanona, procedimientos para su preparacion y medicamentos que contienen estos compuestos | |
ES2150461T3 (es) | Derivados de amidinofenilalanina, proceso para su preparacion, su empleo y agentes que los contienen como anticoagulantes. | |
Keraly et al. | Inhibition by ticlopidine of PAF-acether-induced in vitro aggregation of rabbit and human platelets | |
BR0308601A (pt) | inibidores de carboxipeptidase b de plasma | |
BR9816072A (pt) | Composição clareadora da pele contendo um composto de ácido ascórbico | |
ATE299140T1 (de) | Farnesyl-protein transferase inhibitoren | |
NO20003880D0 (no) | Transfekterende midler som er sensitive overfor reduserende betingelser, farmasøytiske preparater inneholdende disse samt deres anvendelser | |
ES2054904T3 (es) | Procedimiento para la preparacion de peptidos con actividad inhibidora de sistemas enzimaticos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |